DLX-2323 FOR INFLAMMATORY DISEASES

DLX-2323 is a potent, selective single chain variable antibody fragment (scFv) against IL-1β. Due to its small size, it has excellent tissue penetration and can be administered via multiple routes of administration. Given the increasing prominence and understanding of inflammation in various diseases and disorders and the role of IL-1β, DLX-2323 has the potential to neutralize systemic and local IL-1β.